CD4 and neoplasm: Further, interferon-gamma (IFNγ) production has been associated with CD4 CAR T-cell tumor killing and increased patient survival, and IL-4 production by CD4+ T cells has been shown to impact tumor growth, which would support EHHADH as a good candidate [(53, 54), Figure 2E].